These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34883096)

  • 1. Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations.
    Katz JS; Chou DK; Christian TR; Das TK; Patel M; Singh SN; Wen Y
    J Pharm Sci; 2022 Apr; 111(4):919-932. PubMed ID: 34883096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
    Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poloxamer 188 as surfactant in biological formulations - An alternative for polysorbate 20/80?
    Bollenbach L; Buske J; Mäder K; Garidel P
    Int J Pharm; 2022 May; 620():121706. PubMed ID: 35367584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Properties of Novel Excipient Suggest Mechanism for Improved Performance in Liquid Stabilization of Protein Biologics.
    Katz JS; Nolin A; Yezer BA; Jordan S
    Mol Pharm; 2019 Jan; 16(1):282-291. PubMed ID: 30495962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization.
    Kanthe AD; Carnovale MR; Katz JS; Jordan S; Krause ME; Zheng S; Ilott A; Ying W; Bu W; Bera MK; Lin B; Maldarelli C; Tu RS
    Mol Pharm; 2022 Sep; 19(9):3100-3113. PubMed ID: 35882380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Biologics and the Quest for Polysorbate Alternatives.
    Dubey S; Giovannini R
    Trends Biotechnol; 2021 Jun; 39(6):546-549. PubMed ID: 33139073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant Impact on Interfacial Protein Aggregation and Utilization of Surface Tension to Predict Surfactant Requirements for Biological Formulations.
    Vargo KB; Stahl P; Hwang B; Hwang E; Giordano D; Randolph P; Celentano C; Hepler R; Amin K
    Mol Pharm; 2021 Jan; 18(1):148-157. PubMed ID: 33253579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design to biologics development: The polysorbates point of view.
    Brovč EV; Mravljak J; Šink R; Pajk S
    Int J Pharm; 2020 May; 581():119285. PubMed ID: 32240804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation.
    Schiefelbein L; Keller M; Weissmann F; Luber M; Bracher F; Friess W
    Eur J Pharm Biopharm; 2010 Nov; 76(3):342-50. PubMed ID: 20816956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics.
    Morales AM; Sreedhara A; Buecheler J; Brosig S; Chou D; Christian T; Das T; de Jong I; Fast J; Jagannathan B; Moussa EM; Nejadnik MR; Prajapati I; Radwick A; Rahman Y; Singh S
    AAPS J; 2022 Dec; 25(1):6. PubMed ID: 36471030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
    Tomlinson A; Zarraga IE; Demeule B
    Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular and tunable alternative surfactants for biopharmaceuticals provide insights into Surfactant's Structure-Function relationship.
    Cucuzza S; Brosig S; Serno T; Bechtold-Peters K; Cerar J; Kammüller M; Gallou F
    Int J Pharm; 2024 Jan; 650():123692. PubMed ID: 38081561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Injection Site Reactions in Monoclonal Antibody Therapies Caused by Polysorbate Excipient Degradants?
    Singh SK; Mahler HC; Hartman C; Stark CA
    J Pharm Sci; 2018 Nov; 107(11):2735-2741. PubMed ID: 30055223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Fatty Acid Composition in Polysorbate 80 on the Stability of Therapeutic Protein Formulations.
    Pegues MA; Szczepanek K; Sheikh F; Thacker SG; Aryal B; Ghorab MK; Wolfgang S; Donnelly RP; Verthelyi D; Rao VA
    Pharm Res; 2021 Nov; 38(11):1961-1975. PubMed ID: 34845573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brij-58, a potential injectable protein-stabilizer used in therapeutic protein formulation.
    Yue L; Yan Z; Li H; Liu X; Sun P
    Eur J Pharm Biopharm; 2020 Jan; 146():73-83. PubMed ID: 31811896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Surfactants on the Functionality of Prefilled Syringes.
    Wang T; Richard CA; Dong X; Shi GH
    J Pharm Sci; 2020 Nov; 109(11):3413-3422. PubMed ID: 32771345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection.
    Paschen CA; Klemm D; Graf T; Kopf R; Pinto C; Müller C; Bell CH; Pfaff J
    J Pharm Biomed Anal; 2021 Jan; 192():113640. PubMed ID: 33002754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Super Refined™ Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability.
    Doshi N; Fish R; Padilla K; Yadav S
    J Pharm Sci; 2020 Oct; 109(10):2986-2995. PubMed ID: 32679214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution.
    Escobar ELN; Griffin VP; Dhar P
    Mol Pharm; 2024 Mar; 21(3):1490-1500. PubMed ID: 38385557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.
    Dwivedi M; Buske J; Haemmerling F; Blech M; Garidel P
    Eur J Pharm Sci; 2020 Mar; 144():105211. PubMed ID: 31931121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.